5 Stocks Spreadex Traders Fell in Love with

Over the past quarter, the following 5 stocks have been among the most actively traded by Spreadex traders. We rundown the investment case for each.

----------------

Peloton (PTON)

Peleton stock has had a couple of shocking quarters. Which stands to reason after gaining some 850% during the pandemic. Is it ripe to buy the dip or is there worse to come? To get things under control, the board has cut the CEO loose and announced 2,800 job cuts. Has this been done to fix the company? The other possibility is that the firm could be lowering costs to make it a more attractive takeover target. Three giants - Amazon, Apple, and Nike - are rumoured to be considering takeover bids or investments.

Peloton stock currently flirts with its 50-day moving average at $35.

Moderna (MRNA)

Pfizer got most of the headlines for its covid vaccine but having had no previously approved products, Moderna saw a larger boost from covid vaccine sales. Its mRNA vaccine was the first product it brought to market, giving the stock a whopping 2500% at $500 – but has since been more than cut in half. Last quarter, the company cut its sales outlook for the vaccine due to regulatory hurdles. While covid vaccines sales might diminish as the vaccine wanes, the company's cytomegalovirus mRNA vaccine is currently undergoing Phase III trials.

Moderna stock now trading at $160 and below its 100-week moving average.

Easyjet (EZJ)

Last quarter, Easyjet handily beat earnings estimates as European travel remained open despite the surge in omicron. With holiday travel depressed in the previous two years, there is pent-up demand for budget flying. However, the EU announced that the Digital Covid Certificate program would be renewed for another year, which could cap any surge in demand for inter-European travel. Can it sustain the recent rejection and drive the stock towards the $750 zone? If not, traders should focus on the gap down at $560.

EasyJet's share price has crossed above its 200-day moving average, sitting at 675p.

Nvidia (NVDA)

Semiconductor supply is expected to be an issue for the rest of the year, which reduces competitive pressure on Nvidia as demand for chips and graphics cards remains high. A lot of demand for graphics cards is driven by crypto, which might be pressured by a ‘crypto winter’. Nvidia is aiming to disrupt the cloud sector, where firms from Amazon to Google posted record earnings and expect growth to continue. Above its 200-day average, chances of reaching $275 and even $350 again rise. Inversely, crossing below that support, NVDA could find upside pressure at $200, then $180.

Nvidia stock is trading at $239.

Cineworld (CINE)

Cineworld's CEO was optimistic at its last trading update after the firm returned to about 90% of pre-pandemic sales and reported positive cash flow. Traditionally, the first quarter is poor for movies, but the covid situation has disrupted the usual schedule, and the share price is already up 30% this year. Over the next few months, we could see some good box-office pleasers that could push Cineworld's earnings higher, including The Batman, the Tatum/Bullock vehicle, The Lost City, Sonic 2, and Michael Bay's Ambulance. Can the stock get to 56p as a first sign of reversing? Or will the current bounce at its 50-day average prove detrimental for the stock's price down below 30p?

Cineworld share price is currently 39.5p.